期刊文献+

药物治疗的高胆固醇血症患者膳食治疗状况与血脂控制达标率——高胆固醇血症临床控制状况多中心协作研究 被引量:17

Dietary treatment and success rate of control in hypercholesterolemia patients treated with lipid lowering drugs: a multi-center study of current status on clinical control of hypercholesterolemia in China
原文传递
导出
摘要 目的了解接受调脂药物治疗的高胆固醇血症患者膳食状况及膳食对高胆固醇血症控制状况的影响.方法应用食物频数法,于2000年5至8月,对12个省市25家三级甲等医院收治的2136例接受药物治疗的高胆固醇血症患者的膳食状况进行信访调查,其中应答1746例,占81.7%.年龄最小22岁,最大75岁.结果应答者中,控制膳食者占68.3%(1192/1746).其中有75%(894/1192)达到<血脂异常防治建议>膳食合理标准.控制膳食者达标率为28.8%(343/1192),不控制膳食者达标率为13. 6%(12/88),差异有统计学意义 (P<0.01).多因素logistic回归分析控制应用调脂药物等混杂因素后,控制膳食组达标率是不控制膳食组的2.7倍,差异有统计学意义(P<0.01,OR=2.7,95%可信区间为1.4~5.2).结论目前我国高胆固醇血症患者的血脂控制状况不理想,与膳食治疗不足密切相关,合理膳食应作为临床治疗措施积极予以强化. Objective To assess the current status in dietary treatment of hypercholesterolemia and its effects on control of this disease in China. Methods Twenty five Tertiary-A hospitals from 12 provinces in China were selected, in which 2136 patients were recruited who had had hypercholesterolemia and had been receiving lipid lowering treatment for at least 2 months. Serum lipids level was determined for each patient at the time of enrollment, and using a simplified food frequency method carried out dietary intake survey. Patients who take meat of less than 75 g per day and eggs of less than 5 per week, and fried foods of less than 5 times per week, and butter cakes and pastry of less than 5 times per week were considered as having their diet controlled.Results Among 1746 responded patients, 68.3% reported having controlled diet. Among those reported “controlled”, 75% had a diet meeting the requirements suggested by the Chinese Recommendations on Prevention and Treatment of Hypercholesterolemia (CRPTH). The percentage of patients having their serum total cholesterol under control in diet controlled group, according to the CRPTH, was significantly higher than that in diet uncontrolled group (28.8% vs 13.6%, P<0.01). After adjustment for drug treatment and other covariates, the diet controlled group showed a significantly higher rate in control of hypercholesterolemia than the diet uncontrolled group (OR=2.7, 95%CI:1.4~5.2). Conclusion Diet control significantly improves the status in control of hypercholesterolemia and thus should be reinforced in routine clinical practice.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2005年第4期372-375,共4页 Chinese Journal of Cardiology
  • 相关文献

参考文献7

  • 1方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067
  • 2全国高胆固醇血症控制状况多中心研究协作组.高胆固醇血症临床控制状况多中心协作研究——达标率及影响因素[J].中华心血管病杂志,2002,30(2):109-114. 被引量:176
  • 3曹鲁勤 王增武 武阳丰.我国医疗卫生人员对胆固醇与心血管病的认识水平[J].中华心血管病杂志,2002,30:156-160.
  • 4Underbakke G, Plane MB, McBride PE. A survey of dietetics professionals' knowledge of and attitudes toward cholesterol management. J Am Diet Assoc,1993, 93:301-304.
  • 5Gupta R, Jain BK, Keswani P. Awareness of cholesterol as coronary risk factor among general practitioners at Jaipur. J Assoc Physicians India,1993,41:717-719.
  • 6Johnson CL, Rifkind BM, Sempos CT, et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys.JAMA,1993,269:3002-3008.
  • 7Thuraisingham S, Tan KH, Chong KS, et al. A randomised comparison of simvastatin versus simvastatin and low cholesterol diet in the treatment of hypercholesterolaemia. Int J Clin Pract, 2000,54:78-84.

二级参考文献10

  • 1Slamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol a nd risk of premature death from coronary heart disease continuous and graded ? F indings in 356,222 primary screenees of the Multiple Risk Factor Intervention Tr ial (MRFIT). JAMA, 1986,256:2823-2828.
  • 2Castelli WP, Garrison RJ,Wilson PwF, et al. Incidence of coronary heart disea se and lipoprotein cholesterol levels: the Framing ham Study. JAMA, 1986, 256:28 35-2838.
  • 3Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study(4S).Lancet,1994,344:1383 -1389.
  • 4Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary- prevention t ri al with gemfibrozil in middle-aged men with dislipidemia. Safety of treatment ,c hages in risk factors, and incidence of coronary heart disease. N Engl J Med, 1 987,317:1237-1245.
  • 5Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease wit h pravastatin in men with hypercholesterolemia. West of Scotland Coronary Preven tion Study Group. N Engl J Med,1995,333:1301-1307.
  • 6Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary e v ents with lovastatin in men and women with average cholesterol levels: results o f AFCAPS/TexCAPS. Air Force/Texas Coronary Artherosclerosis Prevention Study. JAMA .1998;279:1615-1622.
  • 7Summary of the second report of the National Cholesterol Education Program (NC EP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholestero l in Adults ( Adult Treatment Panel II Report). JAMA, 1993, 269:3015-3023.
  • 8Report of the National Cholesterol Education Program Expert Panel on Detection , Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Pan el. Arch Intern Med, 1998, 148:36-69.
  • 90 Pearson TA, Laurora I, Chu H, et al. The lipid treatment assessment project (L -TAP):a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein choles terol goals. Arch Intern Med, 2000, 160:459-467.
  • 10方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献3188

同被引文献151

引证文献17

二级引证文献249

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部